Fig. 2From: The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictionsModel projections of the number of advanced-stage NSCLC patients receiving second-line therapy in 2016 and 2020 by histology and country. Key: NSQ – non-squamous; SQ – squamousBack to article page